BeyondSpring Inc/ KYG108301006 /
| 2024-05-10 10:00:00 PM | Chg. +0.1400 | Volume | Bid10:54:57 PM | Ask10:54:57 PM | High | Low |
|---|---|---|---|---|---|---|
| 2.4700USD | +6.01% | 8,024 Turnover: 14,632.3977 |
2.3700Bid Size: 200 | 2.5900Ask Size: 100 | 2.4800 | 2.3300 |
GlobeNewswire
05-03
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and U...
GlobeNewswire
04-29
BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results
GlobeNewswire
03-25
BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in...
GlobeNewswire
02-26
BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing Requirements
GlobeNewswire
01-10
BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K
GlobeNewswire
2023-12-18
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
GlobeNewswire
2023-11-07
BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of ...
GlobeNewswire
2023-10-31
BeyondSpring and Professor K. Eisenmann of the University of Toledo College of Medicine Present Post...
GlobeNewswire
2023-10-26
SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at “Targeted Protein Degra...
GlobeNewswire
2023-10-23
SEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of Directors
GlobeNewswire
2023-10-04
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
GlobeNewswire
2023-09-27
BeyondSpring and Leading Cancer Center to Present Poster at SITC’s 38th Annual Meeting
GlobeNewswire
2023-09-07
BeyondSpring to Participate in the R.W. Baird’s 2023 Global Healthcare Conference
GlobeNewswire
2022-01-04
Vaxxinity Appoints Jason Pesile as SVP, Finance & Accounting, and George Hornig to Board of Director...
GlobeNewswire
2021-12-30
BeyondSpring Announces Third Quarter 2021 Financial Results and Provides a Corporate Update
GlobeNewswire
2021-12-15
BeyondSpring Pharmaceuticals Announces New Clinical Data Confirming Plinabulin’s Fast Onset Mechanis...
GlobeNewswire
2021-12-10
BeyondSpring Pharmaceuticals Announces Analysis of New Data on the Plinabulin/Pegfilgrastim Combinat...
GlobeNewswire
2021-12-07
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BeyondSpring Inc...
GlobeNewswire
2021-12-02
BeyondSpring, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investor...
GlobeNewswire
2021-12-01
BeyondSpring Pharmaceuticals Receives Complete Response Letter from the FDA for Plinabulin New Drug ...
GlobeNewswire
2021-11-24
BeyondSpring Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference
GlobeNewswire
2021-11-22
Rafael Holdings Realigns Leadership Team to Support Earlier Stage Pipeline Focus
